ongoing efforts for the improvement of anti-inflammatory and antiproliferative activity of

ongoing efforts for the improvement of anti-inflammatory and antiproliferative activity of oleanolic acid analogues led us to discover 2-cyano-3 12 9 acid (CDDO 1 and related substances. °C cleanly created 3-5 in 38% 15 and 36% produces (total 89%) respectively. The produces are reproducible and we’ve prepared 3-5 many times by this process. These compounds could be conveniently separated by extracting the acidity with aqueous bottom accompanied by column chromatography (find Experimental Section). These were conveniently changed into an individual compound Also. For instance oxidation (e.g. Jones reagent and RuO2-NaIO4 etc.) of alcoholic beverages 5 gave acidity 3 and both acidity 3 and methyl ester 4 had been converted to alcoholic beverages 5 in three guidelines (ketalization decrease with LiAlH4 and deketalization). Acidity 3 could be an important intermediate for the synthesis of abietane and totarane diterpenoids. EXPERIMENTAL SECTION Melting points were determined on a capillary melting point apparatus and are uncorrected. 1H and 13C NMR spectra were recorded at 300 MHz or 75 MHz respectively. Elemental analyses were performed by Atlantic Microlab Inc Norcross GA. THF was purified by a solvent purification system. All other solvents (analytical grade) and reagents were used as received. (±)-(4aβ 8 10 2 3 4 4 6 7 8 8 9 10 10 1 4 acid (3) Its Methyl Ester (4) and (±)-(4aβ 8 10 4 4 6 7 8 8 9 10 10 1 4 3.1 4.6 Hz) 2.73 (1 H ddd = 6.3 13.6 15.8 Hz) 2.58 (1 H dt = 3.2 13.4 Hz) 2.41 (1 H ddd = 3.0 5.2 15.8 Hz) 2.2 (13 H m)8 1.16 1.06 1.04 (3 H each s). 13C SKF 86002 Dihydrochloride NMR (CDCl3): δ 217.0 183.3 144.5 122.4 54.5 48 45.5 40.2 38.34 38.27 36.8 35 25.8 25.5 22.2 21.04 21.03 18 EIMS (70 eV) = 3.5 4.6 Hz) 3.7 (3 H s) 2.73 (1 H ddd = 6.4 13.6 16 Hz) 2.6 Rabbit polyclonal to IL4. (1 H dt = 3.3 13.3 Hz) 2.41 (1 H ddd = 3.0 5.2 16 Hz) 2.3 (12 H m) 8 1.06 (6 H s) 1.03 (3 H s). 13C NMR (CDCl3): δ 216.7 177.4 145.1 121.8 54.6 51.9 47.9 45.6 40.1 38.6 38.3 36.8 35 25.8 25.6 22.1 21 20 18.2 EIMS (70 eV) = 3.8 Hz) 3.68 (2 H s) 2.68 (1 H ddd = 6.6 12.5 15.7 Hz) 2.43 (1 H ddd = 3.3 5.9 15.7 Hz) 2.2 (14 H m)8 1.2 (3 H d = 0.6 Hz) 1.08 (3 H s) 1.06 (3 H s). 13C NMR (CDCl3): δ 217.0 SKF 86002 Dihydrochloride 148 123 67 54.1 47.9 39.7 39 38 SKF 86002 Dihydrochloride 37.1 36.7 34.9 26.1 SKF 86002 Dihydrochloride 26 22.6 21.8 19.7 18.1 EIMS (70 eV) m/z: 276 [M+] (6.1) 245 (100) 227 (10) 203 (6.1). HREIMS: Calcd for C18H28O2 276.2089. Found: 276.2082. Anal. Calcd for C18H28O2: C 78.21 H 10.21 Found: C 77.92 H 10.12 Acknowledgment We thank Dr. Steven Mullen (University or college of Illinois) for the mass spectra. This investigation was supported by funds from NIH Grant 5R03-CA105294. Recommendations 1 Honda T Finlay HJ Gribble GW Suh N Sporn MB. Bioorg. Med. Chem. Lett. 1997;7:1623. SKF 86002 Dihydrochloride (b) Honda T Rounds BV Gribble SKF 86002 Dihydrochloride GW Suh N Wang Y Sporn MB. Bioorg. Med. Chem. Lett. 1998;8:2711. [PubMed] (c) Honda T Rounds BV Bore L Favaloro FG Jr. Gribble GW Suh N Wang Y Sporn MB. Bioorg. Med. Chem. Lett. 1999;9:3429. [PubMed] (d) Honda T Gribble GW Suh N Finlay HJ Rounds BV Bore L Favaloro FG Jr. Wang Y Sporn MB. J. Med. Chem. 2000;43:1866. [PubMed] (e) Honda T Rounds BV Bore L Finlay HJ Favaloro FG Jr. Suh N Wang Y Sporn MB Gribble GW. J. Med. Chem. 2000;43:4233. [PubMed] (f) Honda T Honda Y Favaloro FG Jr. Gribble GW Suh N Place AE Rendi MH Sporn MB. Bioorg. Med. Chem. Lett. 2002;12:1027. [PubMed] 2 Favaloro FG Jr. Honda T Honda Y Gribble GW Suh N Risingsong R Sporn MB. J. Med. Chem. 2002;45:4801. [PubMed] 3 Honda T Favaloro FG Jr. Janosik T Honda Y Suh N Sporn MB Gribble GW. Org. Biomol. Chem. 2003;1:4384. [PubMed] 4 Cassady JM Suffness M. Anticancer Brokers Based on Natural Product Models. Academic Press; New York NY: 1980. p. 254. 5 Snitman DL Watt DS. Synth. Commun. 1978;8:187. 6 Kerwin SM Paul AG Heathcock CH. J. Org. Chem. 1987;52:1686. 7 Caine D. Org. React. 1976;23:1.and recommendations cited therein. 8 Overlapped signals which cannot be.